image credit: adobe stock
Federal authorities have issued urgent advisories – and Medtronic a voluntary product recall – concerning a cybersecurity vulnerability identified in a line of the medical device maker’s insulin pumps.
If exploited, the flaw could result in patients receiving too little or too much insulin, which in extreme cases could result in death.
Diabetic patients with hypoglycemia – low blood sugar – can experience seizures, coma or death. Too little insulin could result in hyperglycemia – high blood sugar – which can potentially lead to diabetic ketoacidosis.
Comments are closed.
